ARCHIVES

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Professional Societies: ASCO Develops Cancer Genetics Curriculum

December 18, 1998

DCCP Payback System Saving $1 Million Year

December 3, 1982

NCI Adds $25 Million to R01, P01 Grant Pool In Fiscal 1990

February 23, 1990

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

March 23, 1990

ASTRO Announces Election Results, Staff Restructuring

September 17, 2010

Cyclamate Committee Finds No Proof Of Carcinogenicity

January 23, 1976